Subscribe To
protara therapeutics announces third quarter 2023 financial results and business update
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24 Company initiat...
November 3, 2023, 12:00 pm
protara therapeutics announces positive preliminary data from advanced-1 phase 1a dose escalation trial of tara-002 in nmibc supporting advancement into phase 2 clinical development
Favorable tolerability observed in patients with NMIBC treated with TARA-002 in ADVANCED-1 trial Anti-tumor activity was observed in all three evaluab...
April 28, 2023, 12:00 pm
Can protara therapeutics (tara) climb 680% to reach the level wall street analysts expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 680.4% in protara...
April 11, 2022, 11:17 am